Spots Global Cancer Trial Database for Maitake for Integrative Cancer Care
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Maitake for Integrative Cancer Care
Official Title: Maitake for Integrative Cancer Care: An Open Label, Uncontrolled Trial in People on Systemic Cancer Therapy
Study ID: NCT06323473
Conditions
Interventions
Study Description
Brief Summary: Maitake is an edible mushroom that is used for both its nutritional and medicinal properties. Human and animal studies have shown Maitake may help improve immune function; however, its effectiveness in people with cancer is not clear. The investigators aim to measure if Maitake has any immunomodulatory effects when given alongside conventional systemic cancer therapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The Centre for Health Innovation, Ottawa, Ontario, Canada
Canadian College of Naturopathic Medicine - Integrative Cancer Centre, Toronto, Ontario, Canada
Contact Details
Name: Adrienne Junek, MD
Affiliation: Centre for Health Innovation
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
